Who invested in BioIQ

3 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$27Mraised across 3 rounds since 2009, from 3 sources

$436KVenture$493KVenture$27MRound

Latest round: Round, $27MMar 2018
Step-upi: 53.8×
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2011201320152017

$436KVenture$493KVenture$27MRound

First round: Venture, $436K
Biggest round: $27M
Usual gap between rounds: 8.2 years

The rounds

Mar 2018
Round$27M1 new
- HealthQuest Capital/ Arboretum
Reported by FinSMEsSEC filing: $26M sold, first sale Mar 2018
Jan 2010
Venture$493K1 returning
- Persistence Partners
Reported by sec.gov
Sept 2009
Venture$436K1 new
- Persistence Partners
From a historical funding record

Founders and team

From BioIQ's own website and the SEC filings it signed: 7 on the team.

Oonagh O'BrienChief Executive Officer
Dr. Robert MordkinChief Medical Officer
Michael RummelChief Laboratory Officer
Mike TesarChief Technology Officer
Ronan RyanChief Operations Officer
Justin BellanteExecutive Officer, Directori
Pete DesaiExecutive Officeri

On the board, as filediAndrew MidlerBrandon CadyMike CottonPatrick CuaPaul McCreadieTodd Creech

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2009Venture2010Round2018

Persistence PartnersHealthQuest Capital/ Arboretum

Everyone who backed them

Persistence PartnersVC firm2rounds

HealthQuest Capital/ Arboretumno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists BioIQ as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.